A method and an apparatus for in vitro testing of catamenial tampon-and-applicator systems are disclosed. The apparatus comprises an in vitro receptacle for accepting tampons deployed during the testing procedure. The in vitro receptacle comprises a sleeve with a tampon-deflecting zone, representing an in vivo vaginal channel with a frontal ...
For example, U.S. Pat. No. 7,166,085 Gann et al. purports to disclose an apparatus for in vitro testing of a tampon and applicator systems. In this patent, there is a target placement position which is achieved by expelling a tampon contained within an applicator into the in vitro receptacle.
For example, US Pat. No. 7,166,085 Gann et al. Claims the disclosure of an apparatus for in vitro testing of tampon and applicator systems. In this patent, there is a predetermined location of the target that is achieved by discharging the tampon contained within the applicator into an in vitro receptacle.
2016-6-9Similarly, in-vivo and in-vitro data sets showed similar stain patterns for the O.b. Flexia tamponsthe absorbed fluid both menstrual in in-vivo testing and test fluid in in-vitro testing is distributed around the tampon. This movement is facilitated by the apertured film that is attached to the tampon in a wing-like design.
A method and an apparatus for in vitro testing of catamenial tampon-and-applicator systems are disclosed. Linvention concerne un procd et un appareil permettant deffectuer un test in vitro de systmes catamniaux de type ensembles tampon et applicateur.
A method and an apparatus for in vitro testing of catamenial tampon-and-applicator systems are disclosed. Linvention concerne un procd et un appareil de test in vitro de systmes tampon-applicateur catamniaux. A method and an apparatus for in vitro testing of catamenial tampon-and-applicator systems are disclosed.
The present invention relates to a catamenial tampon with a joined skirt portion. La prsente invention concerne un tampon hyginique prsentant des parties de bordure runies. A method and an apparatus for in vitro testing of catamenial tampon-and-applicator systems are disclosed.
A method and an apparatus for in vitro testing of catamenial tampon-and-applicator systems are disclosed. Linvention concerne un procd et un appareil de test in vitro de systmes tampon
A method and an apparatus for in vitro testing of catamenial tampon-and-applicator systems are disclosed. Les composants de cet appareil de test sont fabriqus en matriaux rsistant la corrosion. The components of the test apparatus are made of corrosion-resistant materials.
What is the number to copperstone mine in parker az bisbee, arizona wikipedia, the free encyclopediaodern bisbee edit from 1950 to 1960, the sharp population decline changed and the number of residents of bisbee increased by nearly 160 percent when open-pit mining was undertaken and the city annexed nearby areas the peak population was in.
0001This invention relates generally to diagnostic instruments and, more particularly, to systems and methods for performing in-vitro testing of feminine hygiene products such as, for example, catamenial tampon systems.
Ganja Dealer In Bangalore. Bangalore 247 weed delivery,542 likes 16 talking about thise deliver weed in south bangalore take order and do the delivery between 2pm to chat online bangalore on marijuana i boba lovers - youtubear 05, 2016 we asked bangalore folks about marijuana ,weed,cannabis along with there opinion on alcohol with regards to weed.
Success Story Three of a kind MDF particleboard PB and orientated strand board OSB. With many production sites in Europe South Africa North and South America the company supplies highquality woodbased products to over 75 countries around the world. from replacement parts to complete mill maintenance Learn more about
2005-6-17Scented or scented deodorized menstrual tampon L.5470 Unscented menstrual tampon L.5900 Therapeutic vaginal douche apparatus L.5920 Vaginal insufflator L.5940 L.5960
2020-5-5The Keyword Index to Assist Manufacturers in Verifying the Class of Medical Devices is intended to assist manufacturers in confirming the classification of medical device products after application of the Classification Rules for Medical Devices set out in Schedule 1 of the Medical Devices Regulations.This guidance document has been revised to reflect changes to the risk-based
Furthermore, in vitro testing of ferulic acid permeation across the sublingual mucosa demonstrated a doubling of permeation rate for the fiber dosage form over the film dosage form . Due to the high surface area-to-volume ratio of electrospun fiber meshes, water may ingress more rapidly into hydrophilic electrospun materials than into cast films.
The present article is a comprehensive review of the patents related to mucoadhesive vaginal drug delivery systems. ... tampon-like device, va ginal ring, vaginal . ... applicator c artridge.
2015-10-08 20150287102 - systems and methods for providing advertising services to devices by accessing one or more ad databases including third party ad
Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention. ... We also used a mechanical testing apparatus to quantitatively measure composite disintegration and found consistent results, ... or using a tampon applicator. 3.4. Composite fibers increase nanoparticle association with vaginal tissue at 24 h
The apparatus does not include douche solutions. The apparatus is intended and labeled for use in the treatment of medical conditions except it is not for contraceptive use. After filling the therapeutic vaginal douche apparatus with a solution, the patient uses the device
The exemption from the requirement of premarket notification section 510k of the act for a generic type of class I or II device is only to the extent that the device has existing or reasonably foreseeable characteristics of commercially distributed devices within that generic type or, in the case of in vitro diagnostic devices, only to the extent that misdiagnosis as a result of using the ...
2020-5-1The MAUDE database houses medical device reports submitted to the FDA by mandatory reporters 1 manufacturers, importers and device user facilities and voluntary reporters such as health care professionals, patients and consumers. Each year, the FDA receives several hundred thousand medical device reports MDRs of suspected device-associated ...
Title 21 Part 884. e-CFR data is current as of April 29, 2020. ... For noninvasive testing as defined in 812.3k of this chapter and 9 For near patient testing point of care. ... The apparatus is intended and labeled for use in the treatment of medical conditions except it